Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integration of high-throughput genotyping data into pharmacometric analyses using nonlinear mixed effects modeling.

Pharmacogenetics and genomics - 1 Jul 2010

Lehr Thorsten, Schaefer Hans-Guenter, Staab Alexander

Abstract excerpt

OBJECTIVES: High-throughput genotype (HTG) platforms allow the simultaneous screening of many single nucleotide polymorphisms (SNP) across many genes per sample for a reasonable price. This analysis presents an algorithm for the implementation of HTG data in nonlinear mixed effect (NLME) modeling techniques, including model evaluation. The suitability of the developed algorithm is tested by applying it to four...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Genetic
Share to Genotype
Share to High-Throughput Screening Assays

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Models, Genetic

Share to Nonlinear Dynamics

Share to Pharmacogenetics

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 20568315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integration of high-throughput genotyping data into pharmacometric analyses using nonlinear mixed effects modeling.PMID 20568315Read ↗

Comparison of Nonlinear Mixed Effects Models and Noncompartmental Approaches in Detecting Pharmacogenetic Covariates.Semantic proximity Read ↗

An efficient and robust method for analyzing population pharmacokinetic data in genome-wide pharmacogenomic studies: a generalized estimating equation approach.Semantic proximity Read ↗

Multiple single nucleotide polymorphism analysis using penalized regression in nonlinear mixed-effect pharmacokinetic models.Semantic proximity Read ↗

Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapine.Semantic proximity Read ↗

Integrating dynamic mixed-effect modelling and penalized regression to explore genetic association with pharmacokinetics.Semantic proximity Read ↗

Combined Analysis of Phase I and Phase II Data to Enhance the Power of Pharmacogenetic Tests.Semantic proximity Read ↗

Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm.Semantic proximity Read ↗

A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studies.Semantic proximity Read ↗

Effect of SLC22A1 polymorphism on the pharmacokinetics of proguanil in Korean: A semi-physiologic population pharmacokinetic approach.Semantic proximity Read ↗

Multi-model inference using mixed effects from a linear regression based genetic algorithm.Semantic proximity Read ↗

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.Semantic proximity Read ↗

A Bayesian hierarchical nonlinear model for assessing the association between genetic variation and drug cytotoxicity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.